Cargando…

Intratumoral Genomic Heterogeneity May Hinder Precision Medicine Strategies in Patients with Serous Ovarian Carcinoma

Precision medicine, which includes comprehensive genome sequencing, is a potential therapeutic option for treating high-grade serous carcinoma (HGSC). However, HGSC is a heterogeneous tumor at the architectural, cellular, and molecular levels. Intratumoral molecular heterogeneity currently limits th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Kohei, Aimono, Eriko, Tanishima, Shigeki, Imai, Mitsuho, Nagatsuma, Akiko Kawano, Hayashi, Hideyuki, Yoshimura, Yuki, Nakayama, Kentaro, Kyo, Satoru, Nishihara, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235797/ https://www.ncbi.nlm.nih.gov/pubmed/32260152 http://dx.doi.org/10.3390/diagnostics10040200

Ejemplares similares

Olaparib Monotherapy for BRIP1-Mutated High-Grade Serous Endometrial Cancer
por: Nakamura, Kohei, et al.
Publicado: (2020)

Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin’s glands reveals potential new routes for targeted therapies: a case report
por: Nakamura, Kohei, et al.
Publicado: (2020)

Clinical predominance of whole‐exome sequencing to evaluate microsatellite instability status
por: Takamatsu, Reika, et al.
Publicado: (2023)

Genetic Profiling of Malignant Melanoma Arising from an Ovarian Mature Cystic Teratoma: A Case Report
por: Nakamura, Kohei, et al.
Publicado: (2021)

Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors
por: Shimozaki, Keitaro, et al.
Publicado: (2021)

Clinical implications of next‐generation sequencing‐based panel tests for malignant ovarian tumors
por: Saotome, Keiko, et al.
Publicado: (2020)

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
por: Nakamura, Kohei, et al.
Publicado: (2021)

Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling
por: Ueki, Arisa, et al.
Publicado: (2021)

Reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cells
por: Nakamura, Kohei, et al.
Publicado: (2017)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

High Frequency of PIK3CA Mutations in Low-Grade Serous Ovarian Carcinomas of Japanese Patients
por: Ishibashi, Tomoka, et al.
Publicado: (2019)

Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report
por: Hongo, Hiroshi, et al.
Publicado: (2020)

The diagnostic utility of PAX8 immunostaining of malignant peritoneal mesothelioma presenting as serous ovarian carcinoma: A single-center report of two cases
por: Nakamura, Kohei, et al.
Publicado: (2017)

Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells
por: Fu, Sicheng, et al.
Publicado: (2020)

Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification
por: Daimon, Tatsuaki, et al.
Publicado: (2021)

First successful case of platinum‐based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations
por: Omura, Minami, et al.
Publicado: (2021)

KRAS/BRAF Analysis in Ovarian Low-Grade Serous Carcinoma Having Synchronous All Pathological Precursor Regions
por: Nakamura, Kohei, et al.
Publicado: (2016)

Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas
por: Machino, Hidenori, et al.
Publicado: (2023)

CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression
por: Yanai, Yoshinori, et al.
Publicado: (2020)

The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies
por: Kyo, Satoru, et al.
Publicado: (2019)

Sarcopenic Factors May Have No Impact on Outcomes in Ovarian Cancer Patients
por: Nakayama, Naomi, et al.
Publicado: (2019)

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
por: Tone, Alicia A, et al.
Publicado: (2014)

Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell Lines
por: Shanta, Kamrunnahar, et al.
Publicado: (2022)

Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies
por: Kyo, Satoru, et al.
Publicado: (2020)

A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation
por: Kosaka, Takeo, et al.
Publicado: (2019)

Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer()
por: Stanske, Mandy, et al.
Publicado: (2018)

Novel stromal biomarker screening in pancreatic cancer patients using the in vitro cancer-stromal interaction model
por: Nishida, Yasunori, et al.
Publicado: (2020)

A case with life-threatening uterine bleeding due to postmenopausal uterine arteriovenous malformation
por: Sato, Emi, et al.
Publicado: (2015)

Clinical Outcomes of Genotype-Matched Therapy for Recurrent Gynecological Cancers: A Single Institutional Experience
por: Sawada, Kiyoka, et al.
Publicado: (2021)

Effect of Muscle Loss but Not Fat Loss during Primary Debulking Surgery and Chemotherapy on Prognosis of Patients with Ovarian Cancer
por: Nakayama, Naomi, et al.
Publicado: (2022)

Pixel-Level Clustering of Hematoxylin–Eosin-Stained Sections of Mouse and Human Biliary Tract Cancer
por: Inoue, Haruki, et al.
Publicado: (2022)

P16(INK4A) expression might be associated with a favorable prognosis for cervical adenocarcinoma via dysregulation of the RB pathway
por: Ishikawa, Masako, et al.
Publicado: (2021)

Cancer‐associated mutations in normal human endometrium: Surprise or expected?
por: Kyo, Satoru, et al.
Publicado: (2020)

Endometrial Serous Carcinoma: Its Molecular Characteristics and Histology-Specific Treatment Strategies
por: Nakayama, Kentaro, et al.
Publicado: (2012)

Autophagy–physiology and pathophysiology
por: Uchiyama, Yasuo, et al.
Publicado: (2008)

Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
por: Ono, Ruriko, et al.
Publicado: (2019)

Vocal Hinderances
por: Hubbard, Dwight L.
Publicado: (1899)

Enhanced clickability of doubly sterically-hindered aryl azides
por: Yoshida, Suguru, et al.
Publicado: (2011)

Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer Agents
por: Nonomura, Yuki, et al.
Publicado: (2022)

Clinical impact of a cancer genomic profiling test using an in‐house comprehensive targeted sequencing system
por: Hayashi, Hideyuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ncrkv2f8u37j8dop616qr1blns